Clinical Study of Multiple Dose Genakumab for Injection in Chinese Healthy Adults
Clinical trial NCT05894148 · COMPLETED
Trial details
- NCT number
- NCT05894148
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-06
- Primary completion
- 2023-11-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.